#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2668	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2332	336.7	0	.	n	.	0	C45T	SNP	45	45	C	419	419	T	374	T,C	256,76	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2668	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2332	336.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1558	1558	C	374	C	318	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4286	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4055	316.8	0	.	n	.	0	T695C	SNP	695	695	T	1265	1265	C	306	C	264	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4286	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4055	316.8	0	.	n	.	0	G1337A	SNP	1337	1337	G	1907	1907	A	374	A,G	319,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4286	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4055	316.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2541	2541	C	401	C	325	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4286	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4055	316.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2615	2615	A	427	A,C	351,2	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4286	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4055	316.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	3167	3167	C	392	C,T	323,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	539	6028	blaTEM	861	861	99.88	blaTEM.l15.c4.ctg.1	1869	961.3	0	.	p	.	0	M180T	NONSYN	538	540	ATG	1012	1014	ACG	1273;1274;1274	A;C;G,C,A	1076;1085;1088,1,1	.	Betalactam resistance
folP.WHO_L_00516	folP.WHO_L_00516	1	1	539	372	folP	855	855	99.88	folP.l15.c4.ctg.1	2022	55.0	1	SNP	p	R229S	1	R229S	NONSYN	685	687	CGC	1245	1247	AGC	75;75;75	A,G;G;C	65,1;63;67	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	539	892	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3847	69.5	0	.	p	.	0	D95A	NONSYN	283	285	GAC	831	833	GCC	73;74;75	G;C;C	61;57;60	.	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	539	892	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3847	69.5	1	SNP	p	S91F	1	.	.	271	273	TTC	819	821	TTC	73;73;74	T;T;C	57;59;62	gyrA.WHO_G_01105:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	27	414	mtrR	633	633	100.0	mtrR.l6.c4.ctg.1	1750	70.9	1	SNP	p	G45D	1	.	.	133	135	GAC	672	674	GAC	102;102;102	G;A;C	88;85;88	mtrR.WHO_L_00489c:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	250	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c4.ctg.1	1329	56.4	0	.	n	.	0	A197.	DEL	197	197	A	732	732	A	106	A	88	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	988	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3484	84.6	1	SNP	p	D86N	0	.	.	256	258	GAC	992	994	GAC	112;111;111	G;A;C	84;83;87	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	988	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3484	84.6	1	SNP	p	S87R	1	.	.	259	261	CGT	995	997	CGT	112;112;111	C;G;T,G	91;89;86,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	988	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3484	84.6	1	SNP	p	R87I	0	.	.	259	261	CGT	995	997	CGT	112;112;111	C;G;T,G	91;89;86,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	988	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3484	84.6	1	SNP	p	R87W	0	.	.	259	261	CGT	995	997	CGT	112;112;111	C;G;T,G	91;89;86,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	988	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3484	84.6	1	SNP	p	S88P	0	.	.	262	264	TCC	998	1000	TCC	110;111;111	T,A;C;C,T	85,1;90;90,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	666	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3119	64.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1832	1834	GGC	80;80;81	G;G;C	67;66;65	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.18.001	penA.18.001	1	1	27	664	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2828	70.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1478	1480	GCA	101;101;100	G;C;A	86;84;82	penA.18.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.18.001	penA.18.001	1	1	27	664	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2828	70.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1481	1483	ATC	100;102;102	A;T;C	81;84;84	penA.18.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.18.001	penA.18.001	1	1	27	664	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2828	70.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1493	1495	GTG	101;102;101	G,A;T;G	85,1;86;84	penA.18.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.18.001	penA.18.001	1	1	27	664	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2828	70.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1493	1495	GTG	101;102;101	G,A;T;G	85,1;86;84	penA.18.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.18.001	penA.18.001	1	1	27	664	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2828	70.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1997	1999	ACC	98;98;97	A,C;C;C	84,2;84;86	penA.18.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.18.001	penA.18.001	1	1	27	664	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2828	70.2	1	SNP	p	T502V	0	.	.	1504	1506	ACG	2051	2053	ACG	93;93;92	A;C;G	66;70;75	penA.18.001:1:1:T502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.18.001	penA.18.001	1	1	27	664	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2828	70.2	1	SNP	p	T502P	0	.	.	1504	1506	ACG	2051	2053	ACG	93;93;92	A;C;G	66;70;75	penA.18.001:1:1:T502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.18.001	penA.18.001	1	1	27	664	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2828	70.2	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2174	2176	AGC	85;86;86	A,C;G;C	67,1;69;72	penA.18.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.18.001	penA.18.001	1	1	27	664	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2828	70.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2183	2185	GGC	83;82;84	G;G;C	70;70;72	penA.18.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.18.001	penA.18.001	1	1	27	664	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2828	70.2	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2201	2203	CCG	82;82;83	C;C;G	63;68;69	penA.18.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	974	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3432	84.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1789	1791	CCG	93;93;93	C;C;G	78;77;77	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	526	porA	1146	1146	99.56	porA.l6.c4.ctg.1	2150	73.1	0	.	p	.	0	S22G	NONSYN	64	66	AGC	562	564	GGC	97;97;98	G,T,A;G;C	76,1,1;78;85	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	526	porA	1146	1146	99.56	porA.l6.c4.ctg.1	2150	73.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	744	744	C	91	C,T	80,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	514	porB1b	1047	1047	99.43	porB1b.l15.c4.ctg.1	2203	69.9	0	.	p	.	0	N38E	NONSYN	112	114	AAT	673	675	GAA	113;113;113	G;A,G;A	91;91,1;92	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	514	porB1b	1047	1047	99.43	porB1b.l15.c4.ctg.1	2203	69.9	0	.	p	.	0	P175S	NONSYN	523	525	CCA	1084	1086	TCA	83;82;83	T;C;A	70;75;72	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	514	porB1b	1047	1047	99.43	porB1b.l15.c4.ctg.1	2203	69.9	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1213	1215	GTC	96;96;95	G,A;T;C	76,1;77;77	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	514	porB1b	1047	1047	99.43	porB1b.l15.c4.ctg.1	2203	69.9	1	SNP	p	G120K	1	.	.	358	360	AAG	919	921	AAG	95;94;95	A,G;A,G;G,T	81,2;79,1;81,1	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	514	porB1b	1047	1047	99.43	porB1b.l15.c4.ctg.1	2203	69.9	1	SNP	p	D121N	0	.	.	361	363	GAC	922	924	GAC	93;94;95	G,A;A,C;C	78,1;78,2;78	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	514	porB1b	1047	1047	99.43	porB1b.l15.c4.ctg.1	2203	69.9	1	SNP	p	A121D	1	.	.	361	363	GAC	922	924	GAC	93;94;95	G,A;A,C;C	78,1;78,2;78	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	1732	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5347	96.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	278	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1456	57.3	1	SNP	p	V57M	1	.	.	169	171	ATG	699	701	ATG	85;85;85	A;T;G	75;75;74	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	27	1302	tetM	1920	1920	100.0	tetM.l15.c4.ctg.1	3120	125.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Tetracycline resistance
